154 related articles for article (PubMed ID: 36057734)
21. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?
Toshima F; Inoue D; Komori T; Yoshida K; Yoneda N; Minami T; Matsui O; Ikeda H; Gabata T
Jpn J Radiol; 2017 May; 35(5):242-253. PubMed ID: 28258323
[TBL] [Abstract][Full Text] [Related]
22.
Satoh K; Sadowski SM; Dieckmann W; Quezado M; Nilubol N; Kebebew E; Patel D
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):714-721. PubMed ID: 27638678
[TBL] [Abstract][Full Text] [Related]
23. Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional Study.
Jeon SK; Lee JM; Joo I; Lee ES; Park HJ; Jang JY; Ryu JK; Lee KB; Han JK
Radiology; 2017 Jul; 284(1):77-87. PubMed ID: 28092495
[TBL] [Abstract][Full Text] [Related]
24. Utility of FDG-PET Imaging for Risk Stratification of Pancreatic Neuroendocrine Tumors in MEN1.
Kornaczewski Jackson ER; Pointon OP; Bohmer R; Burgess JR
J Clin Endocrinol Metab; 2017 Jun; 102(6):1926-1933. PubMed ID: 28323985
[TBL] [Abstract][Full Text] [Related]
25. [Application of spectral CT in the differentiation of stage T3 and T4a gastric carcinoma].
Xing J; Chai Y; Gao J; Chen Y; Dong J; Yue S
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):580-4. PubMed ID: 27215531
[TBL] [Abstract][Full Text] [Related]
26. Incidental nonfunctioning pancreatic neuroendocrine tumors: Contrast enhanced ultrasound features in diagnosis1.
Yang D; Wang D; Qiu Y; Tian X; Zuo D; Dong Y; Lou W; Wang W
Clin Hemorheol Microcirc; 2022; 80(4):343-352. PubMed ID: 34602462
[TBL] [Abstract][Full Text] [Related]
27. Low-dose whole organ CT perfusion of the pancreas: preliminary study.
Li HO; Sun C; Xu ZD; Miao F; Zhang DJ; Chen JH; Li X; Wang XM; Liu C; Zhao B
Abdom Imaging; 2014 Feb; 39(1):40-7. PubMed ID: 24258077
[TBL] [Abstract][Full Text] [Related]
28. A comprehensive comparison of clinicopathologic and imaging features of incidental/symptomatic non-functioning pancreatic neuroendocrine tumors: A retrospective study of a single center.
Luo G; Liu Z; Guo M; Jin K; Xiao Z; Liu L; Liu C; Xu J; Ni Q; Long J; Yu X
Pancreatology; 2015; 15(5):519-524. PubMed ID: 26365059
[TBL] [Abstract][Full Text] [Related]
29. Surveillance and comparison of surgical prognosis for asymptomatic and symptomatic non-functioning pancreatic neuroendocrine tumors.
Ge W; Zhou D; Xu S; Wang W; Zheng S
Int J Surg; 2017 Mar; 39():127-134. PubMed ID: 28137555
[TBL] [Abstract][Full Text] [Related]
30. Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review.
Mauriello C; Napolitano S; Gambardella C; Candela G; De Vita F; Orditura M; Sciascia V; Tartaglia E; Lanza M; Santini L; Conzo G
Int J Surg; 2015 Sep; 21 Suppl 1():S10-4. PubMed ID: 26118605
[TBL] [Abstract][Full Text] [Related]
31. Assessment of pancreatic adenocarcinoma: Use of low-dose whole pancreatic CT perfusion and individualized dual-energy CT scanning.
Li HO; Guo J; Sun C; Li X; Qi YD; Wang XM; Xu ZD; Chen JH; Liu C
J Med Imaging Radiat Oncol; 2015 Oct; 59(5):590-8. PubMed ID: 26223707
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic perfusion imaging method that reduces radiation dose and maintains image quality by combining volumetric perfusion CT with multiphasic contrast enhanced-CT.
Konno Y; Hiraka T; Kanoto M; Sato T; Tsunoda M; Ishizawa T; Matsuda A; Makino N
Pancreatology; 2020 Oct; 20(7):1406-1412. PubMed ID: 32888809
[TBL] [Abstract][Full Text] [Related]
33. The Clinical Features and Molecular Mechanisms of ACTH-secreting Pancreatic Neuroendocrine Tumors.
Zhang C; Jin J; Xie J; Ye L; Su T; Jiang L; Zhou W; Jiang Y; Wu L; Wang T; Zhong X; Ning G; Shen B; Wang W
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32785672
[TBL] [Abstract][Full Text] [Related]
34. Application of CT-Based Radiomics in Discriminating Pancreatic Cystadenomas From Pancreatic Neuroendocrine Tumors Using Machine Learning Methods.
Han X; Yang J; Luo J; Chen P; Zhang Z; Alu A; Xiao Y; Ma X
Front Oncol; 2021; 11():606677. PubMed ID: 34367940
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcomes in MEN-1 patients with pancreatic neuroendocrine neoplasms: an Israeli specialist center experience.
Oleinikov K; Uri I; Jacob H; Epshtein J; Benson A; Ben-Haim S; Atlan K; Tal I; Meirovitz A; Maimon O; Lev-Cohain N; Mazeh H; Glaser B; Gross DJ; Grozinsky-Glasberg S
Endocrine; 2020 Apr; 68(1):222-229. PubMed ID: 32036501
[TBL] [Abstract][Full Text] [Related]
36. B-mode and contrast-enhancement characteristics of small nonincidental neuroendocrine pancreatic tumors.
Braden B; Jenssen C; D'Onofrio M; Hocke M; Will U; Möller K; Ignee A; Dong Y; Cui XW; Sãftoiu A; Dietrich CF
Endosc Ultrasound; 2017; 6(1):49-54. PubMed ID: 28218201
[TBL] [Abstract][Full Text] [Related]
37. The prognostic value of multidetector CT features in predicting overall survival outcomes in patients with pancreatic neuroendocrine tumors.
Yang B; Chen HY; Zhang XY; Pan Y; Lu YF; Yu RS
Eur J Radiol; 2020 Mar; 124():108847. PubMed ID: 31991300
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
Yadav S; Sharma P; Zakalik D
Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
[TBL] [Abstract][Full Text] [Related]
39. Contrast-Enhanced Ultrasonography Findings Correlate with Pathologic Grades of Pancreatic Neuroendocrine Tumors.
Huang J; Chen J; Xu M; Zheng Y; Lin M; Huang G; Xie X; Xie X
Ultrasound Med Biol; 2021 Aug; 47(8):2097-2106. PubMed ID: 33934943
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcome and long-term survival of 150 consecutive patients with pancreatic neuroendocrine tumors: A comprehensive analysis by the World Health Organization 2010 grading classification.
Deng BY; Liu F; Yin SN; Chen AP; Xu L; Li B
Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):261-268. PubMed ID: 29307515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
